Negative Helicobacter pylori status is associated with poor prognosis in patients with gastric cancer

Cancer

Volumn 115, Issue 10, 2009, Pages 2071-2080

  Marrelli, Daniele ^a   Pedrazzani, Corrado ^a   Berardi, Anna ^a   Corso, Giovanni ^a   Neri, Alessandro ^a   Garosi, Lorenzo ^a   Vindigni, Carla ^a   Santucci, Annalisa ^a   Figura, Natale ^a   Roviello, Franco ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

CagA; Gastric cancer; Helicobacter pylori; Prognosis; VacA

Indexed keywords

CAGA PROTEIN;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; DISEASE ASSOCIATION; FEMALE; GASTRECTOMY; HEALTH CARE FACILITY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER; STOMACH MUCOSA; SURVIVAL RATE; SURVIVAL TIME; UNIVARIATE ANALYSIS;

AGED; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; FEMALE; GENES, BACTERIAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; STOMACH NEOPLASMS; TIME FACTORS;

EID: 65649111266     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24253     Document Type: Article

References (35)

1. Siewert JR, Bottcher K, Stein HJ, Roder JD. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg. 1998;228:449-461.
2. Marrelli D, De Stefano A, de Manzoni G, Morgagni P, Di Leo A, Roviello F. Prediction of recurrence after radical surgery for gastric cancer: a scoring system obtained from a prospective multicenter study. Ann Surg. 2005;241:247-255.
3. Kattan MW, Karpeh MS, Mazumdar M, Brennan MF. Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J Clin Oncol. 2003;21:3647-3650.
4. Forman D, Newell DG, Fullerton F, et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ. 1991;302:1302-1305.
5. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut. 2001;49:347-353.
6. Hocker M, Hohenberger P. Helicobacter pylori virulence factors-1 part of a big picture. Lancet. 2003;362:1231-1233.
7. Plummer M, van Doorn LJ, Franceschi S, et al. Helicobacter pylori cytotoxin-associated genotype and gastric precancerous lesions. J Natl Cancer Inst. 2007;99:1328-1334. (Pubitemid 47394171)
8. Blaser MJ, Atherton JC. Helicobacter pylori persistence: biology and disease. J Clin Invest. 2004;113:321-333.
9. Odenbreit S, Puls J, Sedlmaier B, Gerland E, Fischer W, Haas R. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science. 2000;287:1497-1500.
10. Lee WJ, Lin JT, Shun CT, et al. Comparison between resectable gastric adenocarcinomas seropositive and seronegative for Helicobacter pylori. Br J Surg. 1995;82:802-805.
11. Wu MS, Hung HW, Wang JT, et al. Helicobacter pylori-seronegative gastric carcinoma: a subset of gastric carcinoma with distinct clinicopathologic features. Hepatogastroenterology. 1998;45:2432-2436.
12. Meimarakis G, Winter H, Assmann I, et al. Helicobacter pylori as a prognostic indicator after curative resection of gastric carcinoma: a prospective study. Lancet Oncol. 2006;7:211-222.
13. Marrelli D, Pinto E, De Stefano A, Farnetani M, Garosi L, Roviello F. Clinical utility of CEA, CA 19-9, and CA 72-4 in the follow-up of patients with resectable gastric cancer. Am J Surg. 2001;181:16-19.
14. Sobin LH, Wittekind CH.TNM Classification of Malignant Tumors. 6th ed. New York: John Wiley & Sons; 2002.
15. Figura N, Valassina M, Roviello F, et al. Helicobacter pylori cagA and vacA types and gastric carcinoma. Dig Liver Dis. 2000;32(suppl 3):S182-S183. (Pubitemid 32103472)
16. Kamangar F, Dawsey SM, Blaser MJ, et al. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J Natl Cancer Inst. 2006;98:1445-1452. (Pubitemid 44605589)
17. Hess KR. Graphical methods for assessing violations of the proportional hazards assumption in Cox regression. Stat Med. 1995;14:1707-1723.
18. van Doorn LJ, Henskens Y, Nouhan N, et al. The efficacy of laboratory diagnosis of Helicobacter pylori infections in gastric biopsy specimens is related to bacterial density and vacA, cagA, and iceA genotypes. J Clin Microbiol. 2000;38:13-17. (Pubitemid 30043256)
19. Huang JQ, Zheng GF, Sumanac K, Irvine EJ, Hunt RH. Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology. 2003;125:1636-1644.
20. Kato S, Matsukura N, Tsukada K, et al. Helicobacter pylori infection-negative gastric cancer in Japanese hospital patients: incidence and pathological characteristics. Cancer Sci. 2007;98:790-794.
21. Correa P. Helicobacter pylori infection and gastric cancer. Cancer Epidemiol Biomarkers Prev. 2003;12:238s-241s.
22. Roviello F, Corso G, Pedrazzani C, et al. High incidence of familial gastric cancer in Tuscany, a region in Italy. Oncology. 2007;72:243-247.
23. Kurtenkov O, Klaamas K, Sergeyev B, Chuzmarov V, Miljukhina L, Shljapnikova L. Better survival of Helicobacter pylori infected patients with early gastric cancer is related to a higher level of Thomsen-Friedenreich antigen-specific antibodies. Immunol Invest. 2003;32:83-93.
24. Xue LJ, Su QS, Yang JH, Lin Y. Autoimmune responses induced by Helicobacter pylori improve the prognosis of gastric carcinoma. Med Hypotheses. 2008;70:273-276.
25. Hobsley M, Tovey FI, Holton J. Helicobacter pylori and gastric cancer: neither friend nor foe. Gastroenterology. 2007;132:2076.
26. Rad R, Prinz C, Schmid RM. Helicobacter pylori and prognosis of gastric carcinoma. Lancet Oncol. 2006;7:364-365.
27. Blok P, Craanen ME, Offerhaus GJ, et al. Molecular alterations in early gastric carcinomas. No apparent correlation with Helicobacter pylori status. Am J Clin Pathol. 1999;111:241-247.
28. Hayden JD, Cawkwell L, Dixon MF, et al. A comparison of microsatellite instability in early onset gastric carcinomas from relatively low and high incidence European populations. Int J Cancer. 2000;85:189-191. (Pubitemid 30023066)
29. Kakinoki R, Kushima R, Matsubara A, et al. Re-evaluation of histogenesis of gastric carcinomas: a comparative histopathological study between Helicobacter pylori-negative and H. pylori-positive cases. Dig Dis Sci. 2009;54:614-620.
30. Talley NJ, Zinsmeister AR, Weaver A, et al. Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst. 1991;83:1734-1739.
31. Chow WH, Blaser MJ, Blot WJ, et al. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res. 1998;58:588-590. (Pubitemid 28099460)
32. Munoz N. Is Helicobacter pylori a cause of gastric cancer? An appraisal of the seroepidemiological evidence. Cancer Epidemiol Biomarkers Prev. 1994;3:445-451.
33. Engel LS, Chow WH, Vaughan TL, et al. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst. 2003;95:1404-1413. (Pubitemid 37220460)
34. Hundahl SA, Phillips JL, Menck HR. The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the ''different disease'' hypothesis. Cancer. 2000;88:921-932.
35. Noguchi Y, Yoshikawa T, Tsuburaya A, Motohashi H, Karpeh MS, Brennan MF. Is gastric carcinoma different between Japan and the United States? Cancer. 2000;89:2237-2246.